{"id":"NCT01895777","sponsor":"Boehringer Ingelheim","briefTitle":"Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)","officialTitle":"Open-label, Randomized, Parallel-group, Active-controlled, Multi-centre Non-inferiority Study of Dabigatran Etexilate Versus Standard of Care for Venous Thromboembolism Treatment in Children From Birth to Less Than 18 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09-25","primaryCompletion":"2019-10-16","completion":"2019-11-14","firstPosted":"2013-07-11","resultsPosted":"2020-07-07","lastUpdate":"2020-07-07"},"enrollment":267,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Venous Thromboembolism"],"interventions":[{"type":"DRUG","name":"dabigatran etexilate","otherNames":[]},{"type":"DRUG","name":"standard of care","otherNames":[]}],"arms":[{"label":"dabigatran etexilate","type":"EXPERIMENTAL"},{"label":"standard of care","type":"ACTIVE_COMPARATOR"}],"summary":"The main objectives of this large phase IIb/III paediatric study are to assess the efficacy and safety of dabigatran etexilate relative to standard of care and to document the appropriateness of the proposed dabigatran etexilate dosing algorithm for use in patients from birth to less than 18 years of age.","primaryOutcome":{"measure":"Composite Primary Endpoint","timeFrame":"From the time of randomisation until Week 12, 84 days after randomisation including a visit window of 7 days.","effectByArm":[{"arm":"Dabigatran Etexilate","deltaMin":81,"sd":null},{"arm":"Standard of Care","deltaMin":38,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"= 0.0001"}]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":14},"locations":{"siteCount":65,"countries":["United States","Argentina","Austria","Belgium","Brazil","Canada","Czechia","Denmark","Finland","France","Germany","Greece","Hungary","Israel","Italy","Lithuania","Mexico","Norway","Russia","Spain","Sweden","Switzerland","Taiwan","Thailand","Turkey (TÃ¼rkiye)","Ukraine"]},"refs":{"pmids":["38348778","36150047","33290737","30046738"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":25,"n":176},"commonTop":["Headache","Nasopharyngitis","Vomiting","Pyrexia","Epistaxis"]}}